{"transactions":[{"id":713794,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-07-07T16:07:12.000Z","date":"2026-07-05","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":25370,"derivative":{"exercise_price":14.8,"expiration_date":"2036-07-05","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000932","document":"e665635_4-skerjanec.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119380526000932/e665635_4-skerjanec.xml","form_type":"4"}},{"id":724371,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-29T20:34:08.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":25370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested as of March 27, 2026."}],"balance_after":25370,"derivative":{"exercise_price":10.9,"expiration_date":"2036-03-27","underlying":"Common Stock","underlying_shares":25370},"source":{"system":"sec-edgar","filing":"0001193805-26-000891","document":"e665611_4-skerjanec.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119380526000891/e665611_4-skerjanec.xml","form_type":"4"}},{"id":874722,"issuer":{"id":6185,"kind":"organization","name":"Atrium Therapeutics, Inc.","symbol":"RNA"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-02T23:00:02.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on February 27, 2026 and the shares underlying the options vest in equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":14.75,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193125-26-085918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119312526085918/ownership.xml","form_type":"4"}},{"id":877659,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T20:22:52.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42308,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":28.91,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":42308},"source":{"system":"sec-edgar","filing":"0001193125-26-082290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119312526082290/ownership.xml","form_type":"4"}},{"id":877658,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-27T20:22:52.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10034,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reported Options were disposed of, pursuant to the Merger Agreement, in exchange for a cash payment equal to the excess of the merger consideration of $72.00 over the exercise price."}],"balance_after":0,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001193125-26-082290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119312526082290/ownership.xml","form_type":"4"}},{"id":877657,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T20:22:52.000Z","date":"2026-02-27","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6692,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent shares of Common Stock (inclusive of shares of Common Stock issuable upon settlement of previously reported restricted stock units) disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of October 25, 2025 (the \"Merger Agreement\"), among Novartis AG (\"Novartis\"), Ajax Acquisition Sub, Inc., an indirect wholly owned subsidiary of Novartis, and the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-082290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119312526082290/ownership.xml","form_type":"4"}},{"id":1113800,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:30:40.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":10034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":10034,"derivative":{"exercise_price":33.62,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":10034},"source":{"system":"sec-edgar","filing":"0001599901-25-000121","document":"wk-form4_1749767434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000159990125000121/wk-form4_1749767434.xml","form_type":"4"}},{"id":1113799,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T22:30:40.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":6692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in full on the first to occur of June 10, 2026 or the Issuer's 2026 annual meeting of stockholders, in each case subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":6692,"source":{"system":"sec-edgar","filing":"0001599901-25-000121","document":"wk-form4_1749767434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000159990125000121/wk-form4_1749767434.xml","form_type":"4"}},{"id":1118293,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-06-09T20:08:41.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in monthly increments over a period of one year from the grant date."}],"balance_after":150000,"derivative":{"exercise_price":0.7729,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193805-25-000842","document":"e664611_4-skerjanec.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119380525000842/e664611_4-skerjanec.xml","form_type":"4"}},{"id":1449494,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-07-24T20:11:28.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Additionally, in respect of such appointment, Reporting Person received from Immunic, Inc. a grant of options to purchase up to 50,000 shares of Immunic, Inc.'s common stock, which vest monthly over one year, effective July 22, 2024."}],"balance_after":50000,"derivative":{"exercise_price":1.46,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193805-24-000961","document":"e663799_4-skerjanec.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119380524000961/e663799_4-skerjanec.xml","form_type":"4"}},{"id":1449493,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-07-24T20:11:28.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In relation to Reporting Person's directorship appointment at Immunic, Inc., Reporting Person received an inducement grant of options to purchase up to 100,000 shares of Immunic, Inc.'s common stock, which vest monthly over three years, effective July 22, 2024."}],"balance_after":100000,"derivative":{"exercise_price":1.46,"expiration_date":"2034-07-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-24-000961","document":"e663799_4-skerjanec.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000119380524000961/e663799_4-skerjanec.xml","form_type":"4"}},{"id":1514603,"issuer":{"id":11854,"kind":"organization","name":"Avidity Biosciences, Inc.","symbol":"RNAM"},"owners":[{"id":31759,"kind":"person","name":"Skerjanec Simona","position":1,"cik":"0002022163","reported_name":"Skerjanec Simona","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T22:21:48.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":42308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 14, 2024 and shall vest in substantially equal monthly installments over the three years following the grant date, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":42308,"derivative":{"exercise_price":28.91,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":42308},"source":{"system":"sec-edgar","filing":"0000950170-24-061255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022163/000095017024061255/ownership.xml","form_type":"4"}}]}